Biodegradable biliary stent implantation in the treatment of benign bilioplastic-refractory biliary strictures: Preliminary experience

Giovanni Mauri, Caterina Michelozzi, Fabio Melchiorre, Dario Poretti, Marco Tramarin, Vittorio Pedicini, Luigi Solbiati, Gianpaolo Cornalba, Luca Maria Sconfienza

Research output: Contribution to journalArticle

Abstract

Objectives: To evaluate feasibility, safety, and outcome of patients treated with biodegradable biliary stents for benign biliary stenosis refractory to other treatments. Methods: Between March 2011 and September 2012, ten patients (seven men, three women; age 59 ± 7 years) with recurrent cholangitis due to postsurgical biliary stricture, previous multiple unsuccessful (two to five) bilioplasties, and unsuitability for surgical/endoscopic repair underwent percutaneous implantation of a biodegradable biliary stent. Patients were followed-up clinically and with ultrasound at 1, 3 and 6 months, and then at 6-month intervals. Results: Stent implantation was always feasible. No immediate major or minor complications occurred. In all patients, 48-h cholangiographic control demonstrated optimal stent positioning and stenosis resolution. In a median follow-up time of 16.5 months (25th-75th percentiles = 11-20.25 months) no further invasive treatment was needed. Three patients experienced transient episodes of cholangitis. Neither re-stenosis nor dilatation of the biliary tree was documented during follow-up. No stent was visible at the 6-month follow-up. Conclusions: Percutaneous placement of biodegradable biliary stents represents a new option in treating benign biliary stenoses refractory to treatment with bilioplasty. This technique seems to be feasible, effective and free from major complications. Further investigations are warranted to confirm our preliminary results. Key Points: • Percutaneous biodegradable stents can be used to treat benign biliary stenosis. • They can be used in patients refractory to bilioplasty. • The procedure for insertion appears free from major complication. • Biodegradable stents may represent an alternative device to covered expandable stents.

Original languageEnglish
Pages (from-to)3304-3310
Number of pages7
JournalEuropean Radiology
Volume23
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Stents
Pathologic Constriction
Cholangitis
Therapeutics
Biliary Tract
Patient Safety
Dilatation
Equipment and Supplies

Keywords

  • Benign biliary stricture
  • Biliary tree
  • Bilioplasty
  • Biodegradable stents
  • Percutaneous biliary procedures

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Biodegradable biliary stent implantation in the treatment of benign bilioplastic-refractory biliary strictures : Preliminary experience. / Mauri, Giovanni; Michelozzi, Caterina; Melchiorre, Fabio; Poretti, Dario; Tramarin, Marco; Pedicini, Vittorio; Solbiati, Luigi; Cornalba, Gianpaolo; Sconfienza, Luca Maria.

In: European Radiology, Vol. 23, No. 12, 12.2013, p. 3304-3310.

Research output: Contribution to journalArticle

@article{1de3eec6ce94424e9af191d5a1b887b2,
title = "Biodegradable biliary stent implantation in the treatment of benign bilioplastic-refractory biliary strictures: Preliminary experience",
abstract = "Objectives: To evaluate feasibility, safety, and outcome of patients treated with biodegradable biliary stents for benign biliary stenosis refractory to other treatments. Methods: Between March 2011 and September 2012, ten patients (seven men, three women; age 59 ± 7 years) with recurrent cholangitis due to postsurgical biliary stricture, previous multiple unsuccessful (two to five) bilioplasties, and unsuitability for surgical/endoscopic repair underwent percutaneous implantation of a biodegradable biliary stent. Patients were followed-up clinically and with ultrasound at 1, 3 and 6 months, and then at 6-month intervals. Results: Stent implantation was always feasible. No immediate major or minor complications occurred. In all patients, 48-h cholangiographic control demonstrated optimal stent positioning and stenosis resolution. In a median follow-up time of 16.5 months (25th-75th percentiles = 11-20.25 months) no further invasive treatment was needed. Three patients experienced transient episodes of cholangitis. Neither re-stenosis nor dilatation of the biliary tree was documented during follow-up. No stent was visible at the 6-month follow-up. Conclusions: Percutaneous placement of biodegradable biliary stents represents a new option in treating benign biliary stenoses refractory to treatment with bilioplasty. This technique seems to be feasible, effective and free from major complications. Further investigations are warranted to confirm our preliminary results. Key Points: • Percutaneous biodegradable stents can be used to treat benign biliary stenosis. • They can be used in patients refractory to bilioplasty. • The procedure for insertion appears free from major complication. • Biodegradable stents may represent an alternative device to covered expandable stents.",
keywords = "Benign biliary stricture, Biliary tree, Bilioplasty, Biodegradable stents, Percutaneous biliary procedures",
author = "Giovanni Mauri and Caterina Michelozzi and Fabio Melchiorre and Dario Poretti and Marco Tramarin and Vittorio Pedicini and Luigi Solbiati and Gianpaolo Cornalba and Sconfienza, {Luca Maria}",
year = "2013",
month = "12",
doi = "10.1007/s00330-013-2947-2",
language = "English",
volume = "23",
pages = "3304--3310",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Biodegradable biliary stent implantation in the treatment of benign bilioplastic-refractory biliary strictures

T2 - Preliminary experience

AU - Mauri, Giovanni

AU - Michelozzi, Caterina

AU - Melchiorre, Fabio

AU - Poretti, Dario

AU - Tramarin, Marco

AU - Pedicini, Vittorio

AU - Solbiati, Luigi

AU - Cornalba, Gianpaolo

AU - Sconfienza, Luca Maria

PY - 2013/12

Y1 - 2013/12

N2 - Objectives: To evaluate feasibility, safety, and outcome of patients treated with biodegradable biliary stents for benign biliary stenosis refractory to other treatments. Methods: Between March 2011 and September 2012, ten patients (seven men, three women; age 59 ± 7 years) with recurrent cholangitis due to postsurgical biliary stricture, previous multiple unsuccessful (two to five) bilioplasties, and unsuitability for surgical/endoscopic repair underwent percutaneous implantation of a biodegradable biliary stent. Patients were followed-up clinically and with ultrasound at 1, 3 and 6 months, and then at 6-month intervals. Results: Stent implantation was always feasible. No immediate major or minor complications occurred. In all patients, 48-h cholangiographic control demonstrated optimal stent positioning and stenosis resolution. In a median follow-up time of 16.5 months (25th-75th percentiles = 11-20.25 months) no further invasive treatment was needed. Three patients experienced transient episodes of cholangitis. Neither re-stenosis nor dilatation of the biliary tree was documented during follow-up. No stent was visible at the 6-month follow-up. Conclusions: Percutaneous placement of biodegradable biliary stents represents a new option in treating benign biliary stenoses refractory to treatment with bilioplasty. This technique seems to be feasible, effective and free from major complications. Further investigations are warranted to confirm our preliminary results. Key Points: • Percutaneous biodegradable stents can be used to treat benign biliary stenosis. • They can be used in patients refractory to bilioplasty. • The procedure for insertion appears free from major complication. • Biodegradable stents may represent an alternative device to covered expandable stents.

AB - Objectives: To evaluate feasibility, safety, and outcome of patients treated with biodegradable biliary stents for benign biliary stenosis refractory to other treatments. Methods: Between March 2011 and September 2012, ten patients (seven men, three women; age 59 ± 7 years) with recurrent cholangitis due to postsurgical biliary stricture, previous multiple unsuccessful (two to five) bilioplasties, and unsuitability for surgical/endoscopic repair underwent percutaneous implantation of a biodegradable biliary stent. Patients were followed-up clinically and with ultrasound at 1, 3 and 6 months, and then at 6-month intervals. Results: Stent implantation was always feasible. No immediate major or minor complications occurred. In all patients, 48-h cholangiographic control demonstrated optimal stent positioning and stenosis resolution. In a median follow-up time of 16.5 months (25th-75th percentiles = 11-20.25 months) no further invasive treatment was needed. Three patients experienced transient episodes of cholangitis. Neither re-stenosis nor dilatation of the biliary tree was documented during follow-up. No stent was visible at the 6-month follow-up. Conclusions: Percutaneous placement of biodegradable biliary stents represents a new option in treating benign biliary stenoses refractory to treatment with bilioplasty. This technique seems to be feasible, effective and free from major complications. Further investigations are warranted to confirm our preliminary results. Key Points: • Percutaneous biodegradable stents can be used to treat benign biliary stenosis. • They can be used in patients refractory to bilioplasty. • The procedure for insertion appears free from major complication. • Biodegradable stents may represent an alternative device to covered expandable stents.

KW - Benign biliary stricture

KW - Biliary tree

KW - Bilioplasty

KW - Biodegradable stents

KW - Percutaneous biliary procedures

UR - http://www.scopus.com/inward/record.url?scp=84890550282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890550282&partnerID=8YFLogxK

U2 - 10.1007/s00330-013-2947-2

DO - 10.1007/s00330-013-2947-2

M3 - Article

C2 - 23842947

AN - SCOPUS:84890550282

VL - 23

SP - 3304

EP - 3310

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 12

ER -